Optimizing RSV Prevention
On-Demand Course:
Description
This 1- hour session explores the disease states of RSV in various patient populations, emphasizing key risk factors, clinical presentations, and potential long-term effects. Presenters will discuss updated ACIP recommendations for RSV prevention, focusing on target populations and implementation strategies in pharmacy practice. Additionally, they will review safety and efficacy data from the latest clinical trials on RSV vaccines and monoclonal antibodies, highlighting how these findings shape patient counseling and immunization decisions.
Presenters
Dr. Keri Hurley-Kim, PharmD, MPH
Dr. Sonya Frausto, PharmD, MA, FCPhA
Learning Objectives
At the completion of this activity, participants will be able to:
- Describe the disease states of RSV in pediatric, adult, senior, and pregnant populations, emphasizing risk factors, clinical signs, and long-term health implications.
- Discuss ACIP recommendations for RSV prevention, target populations, and implementation strategies in pharmacy practice.
- Discuss the safety and efficacy data of RSV vaccines and monoclonal antibody from recent clinical trials, assessing how these findings influence patient counseling and immunization decisions.
Registration Fees
CPhA Member | Complimentary |
Non-Member | $30 |
Continuing Pharmacy Education (CPE) Credit
The California Pharmacists Association (#0113) is approved by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Upon completing an evaluation form, participants will be awarded 1 hour (0.1 CEUs) of Continuing Pharmacy Education Credit. A statement of credit will not be issued. Participants may log onto the CPE monitor website using their individual log in to download their statement of credit. Please allow 4 weeks for processing of CPE credits to the CPE monitor. ACPE UAN 0113-0000-25-031-L06-P; 0113-0000-25-031-H06-P. Release date: 09/15/2025 Expiration date: 09/15/2028.
